In animal models of neurological disorders for cerebral ischemia, Parkinson's disease, and spinal cord lesions, transplantation of mesenchymal stem cells (MSCs) has been reported to improve functional outcome. Three mechanisms have been suggested for the effects of the MSCs: transdifferentiation of the grafted cells with replacement of degenerating neural cells, cell fusion, and neuroprotection of the dying cells. Here we demonstrate that a restricted number of cells with differentiated astroglial features can be obtained from human adult MSCs (hMSCs) both in vitro using different induction protocols and in vivo after transplantation into the developing mouse brain. We then examined the in vitro differentiation capacity of the hMSCs in coculture with slices of neonatal brain cortex. In this condition the hMSCs did not show any neuronal transdifferentiation but expressed neurotrophin low-affinity (NGFR p75 ) and high-affinity (trkC) receptors and released nerve growth factor (NGF) and neurotrophin-3 (NT-3). The same neurotrophin's expression was demonstrated 45 days after the intracerebral transplantation of hMSCs into nude mice with surviving astroglial cells. These data further confirm the limited capability of adult hMSC to differentiate into neurons whereas they differentiated in astroglial cells. Moreover, the secretion of neurotrophic factors combined with activation of the specific receptors of transplanted hMSCs demonstrated an alternative mechanism for neuroprotection of degenerating neurons. hMSCs are further defined in their transplantation potential for treating neurological disorders.
INTRODUCTION
tient, thereby avoiding potential tissue rejection. The identification of a source of readily accessible neural progenitors that can be obtained from the individual re-Brain repair has been a particular focus of attention in stem cell (SC) therapy. The benefits of neural SC quiring transplantation therapy without permanent damage could provide a great benefit. transplantation as a means of restoring central nervous system (CNS) diseases or spinal cord injury are quite An important biological finding from several studies is that SCs have a certain degree of flexibility in their recognized (1, 14, 47, 56) . The use of human embryonic neural SCs raises ethical issues as well as practical prob-differentiating capacity, resulting in lineage interconversion between precursor cells originating from the same lems due to transdifferentiation in the adult environment and the need for immunosuppression after grafting. One and different germ layer (1, 15, 16, 20) . Such plasticity is supported by experiments in which bone marrow-advantage of using adult SCs, therefore, is that they can be derived from and be transplanted into the same pa-derived SCs can yield not only blood cells but also mus-cle cells (mesodermal derivatives) and cells bearing neu-IRCCS Ospedale Maggiore of Milan Committee on the Use of Human Subjects in Research. Briefly, bone mar-ronal markers (6, 8, 34, 44, 53, 57) . There is also evidence that mesenchymal stem cells (MSCs) can give rise to row samples were layered on a Histopaque-1077 gradient (specific gravity 1.077 g/ml; Sigma-Aldrich, St. Purkinje neurons in the mouse brain through cell fusion (5, 59) .
Louis, MO, USA) and mononuclear cells plated in Dulbecco's modified Eagle's medium (DMEM) with 4.5 g/ The underlying mechanism of the neurological functional efficacy obtained after MSC transplantation re-L glucose (Biowhittaker, Verviers, Belgium) supplemented with 10% FCS (Sigma-Aldrich), 100 U/ml peni-mains unclear. One possible mechanism may be related to the production of neurotrophic factors from trans-cillin, 0.1 mg/ml streptomycin (Sigma-Aldrich) in 25cm 2 tissue culture flasks (Costar, Cambridge, UK). After planted MSCs. MSCs secrete trophic factors active in neuroprotection, such as nerve growth factor (NGF), 72 h, the nonadherent cells were removed and fresh medium was added. The cultures were reefed weekly, brain-derived neurotrophic factor (BDNF), hepatocyte growth factor, and vascular endothelial growth factor grown until confluence, and expanded for 4-5 passages. Adherent cells were then analyzed by fluorescence-acti-(VEGF) (12) . It is also reported that MSCs stimulate glial cells to produce neurotrophic factors such as BDNF vated cell sorting (FACS) (FACS SCAN flow cytometer, Becton Dickinson). Cells were incubated for 30 and NGF (30) . In the cerebral cortex, neurons in each layer express different neurotrophins and high-affinity min at 4°C with the FITC-conjugated mouse monoclonal antibodies against rat CD34 (clone ICO-115, (trk) receptors (26, 32, 49) . More interesting is that the developing cortex uses neurotrophic signals to direct Santa Cruz), CD45 (clone OX-1), and CD90 (clone OX-7) (Becton Dickinson). FITC-conjugated hamster anti-distinct aspects of neuronal growth and differentiation (7, 25, 35, 41) . Because of the established importance of rat CD29 monoclonal antibody (clone Ha2/5, Becton Dickinson) and rabbit anti-rat c-Kit polyclonal antibody neurotrophins in neuronal survival during development and their potential to promote recovery of neurons after (clone C-19, Santa Cruz) were used. Isotype-identical antibodies served as controls. In experiments of neural injury in the adult nervous system (20, 26, 57) , there has been a great deal of interest in characterizing the intra-differentiation, the hMSCs were harvested and plated on laminin-coated dishes in a B27 Neurobasal medium cellular mechanisms by which neurotrophins may suppress neuronal degeneration due to apoptosis (23) .
(Life Technologies) supplemented with 3-10% FBS (Gibco-BRL) and cultured for 3 weeks. For myoendo-In this study we examined the hMSC potential to exhibit neurogenic and/or neuroprotective properties. Hu-thelial differentiation the hMSCs were cultured in the presence of 10 ng of VEGF (Sigma-Aldrich). man MSCc were characterized in vitro and in vivo for the expression of neural markers, neurotropin low-affin-Organotypic Culture ity (NGFR p75 ), high-affinity (trk) receptors, and neurotrophin production. After plating hMSCs in organotypic Organotypic brain cultures were prepared from brains of 4-day-old mouse pups (P4) as previously described cocultures of neonatal brain sections we found the expression of NGFR p75 , trk receptors, and the release of (43) . Brains were collected under sterile conditions and transferred to Gey's balanced salt solution (Gibco, Grand human neurotrophin-3 (NT-3), neurotrophin-4 (NT-4), and NGF, whereas primary cultures of hMSCs showed Island, NY, USA) containing glucose (6.4 mg/ml). They were transversely sectioned into 400-µm slices with a only the expression of the growth cone associated protein 43 (GAP43). These results were also confirmed Leica Tissue Chopper (Leica). Sections were carefully placed on Millipore Millicell-CM (Millipore Corp., Bed-after the transplantation of hMSCs into the cortex of neonatal mice, suggesting that hMSCs respond to the ford, MA, USA) porous membranes (0.4 µm) in 35-mm culture wells (Nalgene, Naperville, IL, USA) containing neural tissue environment both in vitro and in vivo with neurotrophin expression with both protein release and 1 ml of incubation media (DMEM supplemented with 10% FBS, 25 mg/ml D-glucose, and 2 mM glutamine receptor expression. Furthermore, human MSCs may provide a source of neuroprotective astrocytes for autol-at a final pH of 7.2). Four microliters (20,000 cells) of hMSCs were placed within each organotypic culture ogous cell transplantation therapies in different diseases, including neurodegenerative, ischemic, and traumatic brain sections after 24 h of tissue culture. Under these conditions hMSCs remained randomly distributed within CNS injuries.
the P4 brain sections. Cultures were incubated at 37°C MATERIALS AND METHODS in a 5% CO 2 /95% air humidified environment.
Isolation and Characterization of hMSC in Culture
Transplantation of hMSCs Into the Neonatal Human MSC cultures were established as previously Mouse Brain described (39) from the bone marrow of healthy volunteer subjects (30-55 years of age) after informed con-Balb/C and nude mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and were used sent according to the guidelines of the Fondazione in two different sets of experiments according to institu-adjusting intensity, aperture, and cutting velocity. The laser was directed along the borders of the positive cells. tional guidelines that are in compliance with national (D.I. No. 116, G.U. suppl. 40, Feb. 18, 1992, Circolare Using a 20× objective setting was as follows: aperture 17, intensity 47, speed 10, offset −1. The cut area was No. 8, G.U., 14 Luglio 1994) and international law and policies (EEC Council Directive 86/609, OJ L358, 1 transferred into a microcentrifuge tube cap placed under the section and collected by centrifugation and resus-Dec. 12, 1987 ; Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 1996) .
pended in RLT Buffer (RNeasy Mini Kit, Quiagen, Hilden, Germany) (9). Total RNA was isolated using the The mice were kept in specific pathogen-free conditions, and maintained on acidified water and autoclaved food.
RNeasy Mini Kit according to the manufacturer's instructions and RT-PCR was performed as reported Trimethoprim (60 mg/ml water) and sulfamethoxazole (300 mg/ml water) (Hoffmann-La Roche Inc., Nutley, above. NJ, USA) were given twice a week. The injection coordinates were determined in pilot studies by injecting Immunohistochemistry and Immunofluorescence hMSCs into Balb/C and nude neonatal mouse brains and Neuronal differentiation was tested using the followlocating the injection position in sectioned brains. The ing specific anti-human antibodies: neurofilament-M hMSCs were labeled with fluorescent dyes with a protein (1:100; Chemicon), neuronal-specific enolase PKH26 Red Fluorescent Cell Linker Kit (Sigma Chemi-(NSE) (1:2000; Polysciences), glial fibrillary acidic procal Co., St. Louis, MO, USA) before implantation, as tein (GFAP) (1:50; Boehringer Mannheim, Indianapolis, previously reported (33) . By using bregma as a land-IN, USA), β-tubulin type III (TuJ1) (1:100; Sigma), mimark, 3 µl of 50,000 hMSCs were slowly injected over crotubule associated protein (MAP-2ab isoform) (1:200; a period of 5 min into the lateral right cortex of cryoan-Sigma), nestin (1:500; Pharmingen), galactocerebroside esthetized 4-day-old mice by using a stereotactic device.
(Gal-C) (Promega, South San Francisco, CA, USA), The needle of a 15-µl Hamilton was left in position for trkA, trkC, and NGFR p75 (1:500; Promega). For quantitaapproximately 3 min and gradually withdrawn. Fifty tive analysis, after immunostaining, coverslips were Balb/C mice were transplanted with hMSCs and sacricounterstained with DAPI and anti-human lamin A/C ficed at day 30.
(Novocastra, 1:200). Immunostaining of MSCs was also Of the nude mice, 30 were harvested either after 7 performed using monoclonal antibodies against CD31 and 45 days after hMSC transplants. Brain tissues were (1:100; Santa Cruz), VE-Cad (1:100; Santa Cruz), CD34 removed and grossly dissected into four equal sized co-(1:50; Becton Dickinson), and STRO-1 (1:150; Sigma). ronal sections. Specimens were then frozen in liquid ni-Coverslips tested for neuronal markers were fixed in 4% trogen-cooled isopentane and cut on a cryostat into 7-µm paraformaldehyde (in PBS, pH 7.2) for 30 min, followed serial sections. Grafted cells were detected by immunoby three washes (10 min each) in PBS, pH 7.2. Nonneufluorescence assays for specific human antigens and the ronal antibodies were tested on coverslips fixed in ethacell nuclei were stained for 15 min at 37°C with 4′,6nol 70% in PBS for 1 min and permeabilized for 5 min diamidino-2-phenylindole (DAPI). with 0.5% Triton X-100 in PBS. After washing with PBS, cells were incubated with appropriate secondary Laser Microdissection Analysis of Human FITC/TRITC-conjugated IgG antibodies (1:100) for 1 h Transplanted hMSCs at room temperature and examined by a Leica TCS 4D The Leica AS LMD (Leica Microsystems, Germany) confocal microscope. has been used to perform the isolation of the single cells from brain frozen sections. Sections of 8-µm thickness Fluorescent In Situ Hybridization (FISH) were prepared from frozen tissue and mounted on glass on Transplanted Mice slides. These sections were stained without fixation by immunohistochemistry for identification of human lamin FISH analysis was performed on frozen neonatal mouse brain tissue sections. The slides were first treated A/C nuclei. The slides were mounted on the Leica system with the sections downwards (10). Individual cells for 30 min with Histochoice Tissue Fixative (Sigma-Aldrich) and sections were dehydrated in 70%, 80%, of the same brain area were pulled from sections by directing the laser through the sections over the selected and 95% alcohol. The denaturation was performed at 70°C for 2 min in 70% deionized formamide in 2× SSC cell. The RT-PCR and ELISA analyses were performed from 500 microdissected cells expressing the human and slides dehydrated again at −20°C. The hybridization was performed overnight at 37°C. A Cy3-labeled human lamin A/C+ nuclei. The isolation of such cell numbers by laser microdissection was selected after several pre-Pan Centromeric probe and a FITC-labeled Pan Centromeric probe were used to identify human and mouse liminary experiments of genome or expression profile performed from a range of 20-1500 cells. The instru-cells, respectively. Nuclei were counterstained with DAPI. Positive and negative controls were nontrans-ment works with a laser used to isolate the target after planted human and mouse brain sections. Slides were Only samples expressing the human GAPDH gene were considered and we designed specific primers for observed using a Leica TCS 4D confocal microscope. several neural markers in unique regions on the basis GEArray Gene Expression and RT-PCR Analysis of deposited human sequences. Briefly, total RNA was of hMSCs extracted with Trizol from frozen brains and tissue slices after positive immunohistochemical identification of Total RNA was isolated from Balb/C and nude brain sections injected with hMSCs using Trizol reagent (In-transplanted cells. The contaminating genomic DNA was eliminated by DNAse I digestion at 37°C for 30 vitrogen) as described by the manufacturer. Aliquots of total RNA (3 µg) were used to analyze the human neuro-min (Roche, Hoffmann-La Roche Ltd), and samples (3 µg total RNA) were retro-transcribed in a final volume trophin and receptor gene expression profile by GEArray technology (Cat. No. HS-018N-2, SuperArray Inc., of 40 µl by SuperScript II RT (GIBCO; 50 min at 42°C) according to the manufacturer's protocol in the presence Bethesda, MD, USA). The biotin deoxyuridine triphosphate (dUTP)-labeled cDNA probes were generated by of oligo(dT) primers (500 pmol) and RNAsin Ribonuclease Inhibitor (Promega). cDNA was amplified for GEArray Ampolabeling-LPR kit. Total RNAs were annealed with random primers at 70°C for 3 min, then 40 cycles (35 for GAPDH) at annealing temperature optimized for each set of primers (50 pmol each), in the reverse transcribed to cDNA at 37°C for 25 min. These cDNAs were amplified by PCR using gene-specific presence of 0.5 U of AmpliTaq Gold (Applied Biosystems). RT-PCR for several human neurotrophins and primers and biotin 16-UTP (Roche). The PCR was performed as described by the following protocol: the first their receptors' expression was also performed under the following conditions: 94°C 5 min, then 35 cycles at step at 85°C for 5 min, then 30 cycles (85°C 1 min, 50°C 1 min, 72°C 1 min), and the last step at 72°C for 94°C 40 s, 68°C 40 s, 72°C 1 min. Human or murine brain cDNAs were amplified as positive controls, while 5 min. After prehybridization membranes were incubated with biotin-labeled cDNAs overnight at 60°C. in negative controls reverse transcriptase was omitted. Membranes were then washed and blocked with GEAblocking solution. The chemiluminescent detection ELISA Assay was performed by alkaline phosphatase-conjugated Supernatants of the organotypic brain tissue cultures streptavidin and CDP-star substrate. Chemiluminescence and transplanted brain specimens were collected for neuwas visualized by exposure to electrochemilumiscence rotrophins measurement. Human NT-3, neurotrophin 4/5 film. Data were acquired with a scanner (Epson) and
(NT-4/5), brain-derived growth factor (BDGF), and NGF the digital image was converted to raw data file using were measured using commercially available kits ScanAlyze Software. The data acquired were analyzed (Chemicon, Temecula, CA, USA) according to the manwith GEArray Analyzer Software (SuperArray). The exufacturer's instructions. The supernatant of the organopression level of each gene was compared with the sigtypic brain sections was collected after 7 days of coculnals derived from the housekeeping gene human glycerture with the hMSCs. Transplanted hMSCs expressing aldehyde 3-phophate dehydrogenase (GAPDH) (three the human lamin A/C antigen were isolated from differspots in each array), whereas negative values were transent brain areas by laser dissection and homogenized. To formed to zero. Expression of neural markers in hMSCs test the species specificity of the ELISA kit, the specific was also investigated by means of RT-PCR technique expression level of each human neurotrophin was comand the primers used were: Hu-NSE_for ATGTGAT pared with the signals derived from the uninjected mouse CACGCCTGGCTAATA and Hu-NSE_rev GAACC brain areas (five specimens for each area per single neu-TAGGGTTGGGGAGAGAT (product size: 325 bps); rotrophin). No detection of human neurotrophins was Hu-GAP43_for TGATGCTGCCACAGAGCAGG and observed in all controls uninjected mouse brain areas. Hu-GAP43_rev TGGGAAAGGACAGACTCACAGAC GTG (product size: 498 bps); Hu-MAP2_for TGAG
In Vitro Neurotrophin Stimulation of hMSCs GATGTCACTGCTGCACTC and Hu-MAP2_rev TGT and Angiogenesis Assay TGCAAATGGAAATCAGGTC (product size: 237 bps); Hu-GFAP_for GTGACTCATCCTCTTGAAGA In order to verify whether neurotrophin stimulation can mimic the results obtained with the ELISA assay TGC and Hu-GFAP_rev ACAGATCCCACCAGTCT GCTCAC (product size: 442 bps); Hu-β-tubulinIII_for from the organotypic brain tissue cultures and transplanted brain specimens, 60-70% confluent cultures of AGATGTACGAAGACGACGAGGAG and Hu-β-tubu-linIII_rev GTATCCCCGAAAATATAAACACAAA (pro-adult hMSCs were incubated with NGF (50 ng/ml) and NT-3 (10 ng/ml) in combination or alone, in DMEM duct size: 315 bps); Hu-GAPDH_for TCCCCACTGC CAACGTGTCAGTG and Hu-GAPDH_rev ACCCTG (Biowhittaker) supplemented with 10% FCS (Sigma-Aldrich), 100 U/ml penicillin, and 0.1 mg/ml streptomy-TTGCTGTAGCCAAATTCG (product size: 268 bps). cin (Sigma-Aldrich). Human MSCs were analyzed for cent membrane binding dye, provided a quick and convenient method to track the fate of the grafted cells in their release of angiogenic factors on Angiokit (TCS Cell Works Ltd, Buckingham, UK) according to the manu-the brain. Thirty days after transplantation only 12 neonatal Balb/C mice survived, and the examination of facturer's protocols. Briefly, the 3-day-old medium from human MSCs was added at different dilutions (1:1; 1:2;
cryostat sections by fluorescent microscopy revealed that 7 from these Balb/C mice contained labeled hMSCs 1:3) to the seeded human endothelial cells (HUVEC) in a 24-well plate. Control wells that received no condi-( Fig. 1E, F) . RT-PCR analysis of the counterstained sections showed the expression of human GAPDH (Fig. tioned medium were cultured in the presence of VEGF (2 µg/ml) and suramin (2 mM). Cultures were monitored 1M). Thirty days after MSC transplantation neurons were shown to express the human neuronal antigens daily for the tubules formation and fixed for immunohistochemistry analysis after 12 days of culture. Staining MAP-2ab isoform and human neurofilament 160 kDa (NF-160kD) (Fig. 1G, H) in the brain of one mouse of procedure for the expression of CD31 was performed as previously described (18) . After the immunostaining, the seven transplanted animals expressing the human GAPDH in brain specimens (Fig. 1M) . No hMSC cells express-degree of angiogenesis was assessed using the TCS "AngioSys" software package (TCS CellWorks, Cat No.
ing the human GalC, a marker for oligodendroglia, were found in the transplanted mice brains (Fig. 1K) . The ZHA-1800), which reduces in width to a single pixel each stained vessel. We analyzed the pixels' total num-hMSCs-derived neurons were positive for the human centromer nuclei by FISH as well ( Fig. 1I ) and exhibited ber in six independent microscopic fields (40×). All data are expressed as percentage of the control wells cultured characteristic polar morphologies with segregation of neurites into dendrites and axons with prominent fiber in the presence of VEGF and suramin (referred as 100%) and expressed as the mean ± SD values.
bundles running alongside, indicating a probable state of mature neurons. These cells were detected in layer 4 of the cortex of 10 serial brain sections and their number RESULTS was 15 ± 6 (SD) cells/section. Some of them were found Characterization of Cultured hMSCs adjacent to host GFAP+ astrocytes (Fig. 1L) . No human Typically, hMSCs are isolated from bone marrow by nuclei were detected in control mice after FISH labeling their adherence to plastic (40) . Most of cultured adherent (Fig. 1J ). Few hMSCs-derived cells expressing human cells expressed CD29 and CD90 (data not shown). In GFAP with bipolar morphology and not the typical contrast, the majority of adherent cells were negative for branching pattern were found. Moreover, fluorescent CD34 and CD45. A small fraction of the adherent cells cells were observed clustered at the injection site, sugexpressed c-Kit. Thus, we confirmed that the adherent gesting that hMSCs did not migrate throughout the brain cells were MSCs. To verify the neuropotential phenoof Balb/C mice. In this series of experiments of intracortype of the hMSCs, we subjected these cells in vitro tical injections, 38 mice failed to survive. We attributed to neural differentiation using B27 neurobasal medium the poor cell survival to the local inflammation and imsupplemented with 3-10% FBS. In these conditions sevmunological rejection related to the xenotransplant. We eral hMSC were positive for the expression of vimentin therefore repeated the injections into nude mice. In these antigen ( Fig. 1A) and coexpressed β-tubulin III and experiments most of the transplanted mice survived after GFAP (Fig. 1B ) (11 ± 4.3% of the cells) displaying bicell transplantation (Table 1) . polar morphologies, whereas there was no expression of At 7 days postinjection, the overall distribution of other neural markers, NGFR p75 , or trk receptors. How-hMSCs throughout the brain was essentially identical in ever, in the presence of 10 ng of VEGF, the hMSCs (7 all nude animals examined. The transplanted cells were ± 2.9% of the cells) coexpressed the α-smooth muscle detectable by virtue of their human nuclei by FISH analactin (α-SMA) (Fig. 1C ) and desmin (Fig. 1D ) myoenysis and PKH expression. In the cortex, a large number dothelial markers. The RT-PCR analysis of these cells of donor cells were found ipsilateral to the injection site showed only the expression of GAP43. Furthermore, the throughout the cortical layers, spanning from the ante-hMSCs did not secrete detectable neurotrophins in these rior commissure to the cingulate cortex ( Fig. 2A) . Many in vitro basal experimental conditions. hMSCs, however, were also detected lining the ependyma throughout the ventricles. No human MSCs were Transplantation of hMSCs Into Neonatal localized into the cerebellum. All these data indicated P4 Mouse Brain that hMSCs can migrate in multiple directions after intracortical transplantation in nude mice. hMSCs express-To determine whether hMSCs can engraft into neonatal P4 brain, we initially injected 50,000 PKH- 26- ing human centromer nuclei also were localized to areas undergoing active postnatal neurogenesis, including the labeled cells into the right parietal cortex of neonatal Balb/C and nude mice. The use of PKH-26, a fluores-Islands of Calleja (Fig. 3A-D) (54) in the ventral fore- brain and the subependyma of both the frontal cortex lamin A/C+ hMSC-derived cells showed a production of human NT3 and NT4 after 7 days of transplantation and olfactory bulb (4,5). The RT-PCR analysis from dissected human lamin A/C+ cells demonstrated the ex-from the cortical graft (hNT3 19.42 ± 6.88 pg/ml; hNT4 16.215 ± 1.97 pg/ml), ventral forebrain (hNT3 23.625 ± pression of the human marker GAPDH (Fig. 3H) . Moreover, the RT-PCR with oligonucleotides specific for 17.677 pg/ml; hNT4 1.45 ± 0.10 pg/ml), ventricles (hNT3 17.975 ± 5.21 pg/ml; hNT4 14.57 ± 1.76 pg/ml), human NT3, NT4, NGF, trkA, trkB, and trkC revealed appearance of transcripts for several of these human and olfactory bulb (hNT3 25.985 ± 7.44 pg/ml; hNT4 8.682 ± 5.403 pg/ml) (mean ± SEM; n = 6) ( Table 2) . genes both 7 and 45 days after transplantation (Figs. 2  and 3) . The ELISA analysis of the laser dissected human At 45 days postinjection, transplanted hMSCs were hMSCs (50,000) were injected into the lateral right cortex of cryoanesthetized 4-day-old mice by using a stereotactic device. Before transplantation, the hMSCs were labeled with a PKH26 fluorescent vital dye. In the first experiments, from the 50 Balb/C transplanted newborns, only 12 mice survived and were sacrificed after 30 days. Seven from these surviving animals showed clusters of fluorescent PKH26+ cells into their transplanted brains. We repeated the same experiments into nude mouse brains, and the animals were sacrificed 7 and 45 days after (n = 30 for each group). From the 28 animals that survived after 7 days of transplantation, 26 animals were positive for the PKH26 staining while only 18 from the 26 animals that survived after 45 days of transplantation showed PKH26+ cells into the injection site and distributed in different brain areas.
able to form clusters of 12-20 human GAP43+ cells, further neuronal markers such as MAP-2, NeuN, and neurofilament. Moreover, the PKH26+ hMSCs did not round or oval in shape, close to host striatal neurons (Fig. 3F) . Moreover, the human GAP43+ cells did not label for the astrocytic marker GFAP or the oligodendrocytic GalC. We then examined the expression of the exhibit characteristic polar morphologies with segregation of neurites into dendrites and axons with prominent neurotrophin receptors. Double staining of PKH26+ hMSCs with anti-human nuclear lamin A/C (Fig. 5E ) fiber bundles running alongside, indicating a probable state of immature neurons. No donor-derived mature and trkC (Fig. 5F, J) showed that 55 ± 3.7% of lamin A/C+ cells expressed trkC. A few of these cells were neurons and oligodendrocytes were found in the transplanted mouse brains by immunocytochemical analysis binucleated, suggesting a cell fusion process ( Fig. 5E-H) . NGFR p75 + cells were also observed (35 ± 0.6% of for human MAP-2ab, NF160, and GalC (data not shown). Colocalization of human nuclei and the astrocyte marker the lamin A/C+ cells). Immunostaining for trkA and trkB receptors was negative in all coculture wells. Most GFAP was unequivocally demonstrated at the graft-host border (i.e., within the area of mouse GFAP-positive re-of the applied hMSCs remained aggregated in clusters within the explants. Moreover, several lamin A/C+ hMSCs active astrocytes surrounding the graft core) (Fig. 3G ). Several transplanted hMSCs were also found close to were also found around the explants after 7 days of coculture ( Fig. 5A ). Most of these cells coexpressed the blood vessels coexpressing the human centromer nuclei and Ve-cadherin after 45 days of transplantation, whereas PKH26 dye ( Fig. 5B ) and the human trkC (85 ± 5.9%) ( Fig. 5C ), while few of them coexpressed NGFR p75 (4 ± these cells were negative for human KDR (marker for endothelial and hematopoietic stem cells) and CD45 (a 0.7%). To elucidate the possible production of human soluble factors by hMSCs in the organotypic brain co-marker of all mature nucleated hematopoietic cells) ( Fig.  4A-D) . The ELISA analysis of the laser dissected cultures, analysis of the supernatants using specific human ELISA for human neurotrophic factors (NGF, hMSC-derived cells after 45 days of transplantation confirmed the production of human NT3 and NT4 from the BDNF, NT3, NT4/5) was performed. This revealed that after 7 days of cocultures, the hMSCs secrete NT3 (140 ± cortical graft (hNT3 16.39 ± 0.37 pg/ml; hNT4 18.5 ± 1.25 pg/ml), ventral forebrain (hNT3 14.29 ± 0.36 pg/ 23.4 pg/ml), NT4 (121 ± 16 pg/ml), and NGF (89 ± 17.7 pg/ml), but no traces of BDNF were found in these con-ml; hNT4 8.85 ± 0.75 pg/ml), ventricles (hNT3 22.687 ± 5.41 pg/ml; hNT4 3.391 ± 2.012 pg/ml), and olfactory ditions (mean ± SEM; n = 5). In order to improve these observations, we analyzed the human neurotrophin and bulb (hNT3 25.812 ± 4.93 pg/ml; hNT4 4.143 ± 2.30 pg/ml) (mean ± SEM, n = 6) ( Table 2) . receptor gene expression profile by RT-PCR analysis (Fig. 5M ) and GEArray technology (Fig. 6 ) of the or-hMSC Application Into Organotypic Cultures ganotypic cocultured hMSCs (12, 29) . The expression patterns of human NT3, NT4, and NGF mRNA were hMSCs were labeled with PKH26 and cocultured for consistent with the results of ELISA. 7 days with brain sections of Balb/C and nude P4 mice. The application of hMSCs to the brain explants did not
In Vitro Neurotrophin Stimulation of hMSCs result in the expression of neuronal, astrocytes, and oliand Angiogenesis Assay godendroglial markers in hMSCs. PKH26+ hMSCs only expressed the early neuronal marker βIII-tubulin (data We further examined whether the in vivo release of neurotrophins may correspond to an autocrine pathway not shown). We did not observe the expression of any required to generate neuroglial cells from hMSCs. For recognized the expression of neurotrophins and their receptors in hMSCs. this purpose we decided to treat hMCSs with the same neurotrophins expressed in the organotypic brain cocul-These results may suggest that the release of neurotrophins in hMSCs is not sufficient for their neural dif-ture experiments, namely NGF and NT3. Human MSCs were cultured for 15 days in the presence of these neuro-ferentiation and seems to be dependent on cell-cell contact in the developing brain. A tube formation assay trophins (50 ng/ml of NGF; 10 ng/ml of NT3), followed by immunostaining with anti-MAP-2ab, GAP43, GFAP, (Angiokit, TCS CellWorks Ltd, Buckingham, UK) was also used to determine the capability of conditioned and GalC antibodies. NGF, NT3, and combination of the two did not induce any neural cell differentiation. As for hMSCs media to regulate the angiogenesis (Fig. 4E-G) .
Increasing conditioned media of hMSCs (1:1, 1:2, 1:3) the neural cell markers, the immunostaining for NGFR p75 , trkA, trkB, and trkC was negative in all the tested condi-added to the Angiokit wells seemed to promote the formation of capillary-like structure (Fig. 4F ) in a dose-tions. To further test the hypothesis that neurotrophins and their receptor induction may be related to soluble dependent manner after 10 days of culture. Counts of total CD31+ vessels were performed by using an in-factors, hMSCs were cultured with different dilutions (1:1, 1:2, 1:3) of the condition medium obtained from verted microscope, and the results found in VEGF-stimulated cultures (Fig. 4E) were expressed as 100%. The the organotypic brain sections. In these conditions, ELISA, immunostaining and GEArray analysis did not count of CD31+ vessels confirmed the high angiogenetic potential of the hMSCs conditioned medium (58.19%) vivo. The in vitro analysis using different cell induction protocols further confirmed the reduced capability of (Fig. 4G ). No tube formation was observed when HUVEC from the Angiokit were cultured with conditioned media hMSCs to transdifferentiate, overcoming the barriers of germ layer commitment. These data further expand our obtained from human fibroblasts (data not shown).
previous observations in different subpopulations of hu-DISCUSSION man adult bone marrow cells (6). To further test the neural potential of the hMSCs, we injected these cells into This study examined the capacity of adult hMSCs to differentiate into the neural lineage both in vitro and in the lateral parietal cortex of neonatal Balb/C and immu- Host GFAP+ cells (magenta in A) were found near these vessels. Several small rounded human lamin A/C cells (green in C; arrowhead in C), similar to the hematopoietic/ endothelial precursors, were found at the host vascular border and within the wall vessel. These cells did not express any of the neuronal and glial markers but were positive for human Ve-cadherin (magenta in D; arrowhead in D). A tube formation assay was also used to determine the capability of conditioned MSCs media to regulate the angiogenesis (E-G). The human endothelial cells (HUVEC) from the Angiokit differentiate in a network of CD31+ vessels in the presence of VEGF (E). Capillary sprouts, tubular structures, and vessel arborization in human MSC conditioned medium after 10 days of culture is shown in (F). (G) The CD31+ tubular structures obtained in the different conditions were quantified using the TCS "AngioSys" software package and expressed as a percentage of the number of the tubular structures obtained from the VEGF-treated HUVEC cells (referred as 100%). nodeficient nude mice and into slice culture tissues ob-rotrophin receptors and neurotrophin release within the grafted regions. This is probably the effect of the local tained from the same brain areas. One of the major problems of our study was the high mortality rate of neural microenvironment on the grafted hMSCs. To complement these data, hMSCs respond in vitro to a transplanted P4 Balb/C mice and the low levels of engraftment in these animals, whereas the results obtained similar epigenetic signal(s) from organotypic brain tissues and demonstrate in vitro a broad capacity to express with nude mice demonstrated improvement of the engraftment with migration of hMSCs from the graft. human neurotrophins. Additionally, the GEArray and RT-PCR analysis confirmed the expression of human These data suggest that the status of the immunoprivileged brain should be reconsidered in relation to the in-neurotrophins in these conditions. This in vitro system could thus be considered as a developing microsystem, flammatory response and immune system activation produced after brain xenotransplantation. The low percentage inducing neurotrophin production from hMSCs that is presumably the result of a partial reprogramming of the of hMSC-derived neural cells found in the brain after grafting confirms this statement.
hMSC genome at different stages of maturation. These data would indicate that hMSCs may have neuroprotec-On the contrary, cells grafted into nude mice demonstrated better survival, migration, and expression of neu-tive capacity after direct cell-cell contact in developing Figure 6 . GEArray technology of the organotypic cocultured human MSCs. After 7 days of coculture, we found the expression patterns of human trkA, trkC, NT3, NT4, and NGF mRNA.
brain tissues, becoming able to produce neurotrophic releasing neurotransmitters at synapses (22) . No study has shown so far generation of functional neurons from factors (12, 30) .
MSCs have great promise as a source for introducing adult bone marrow stem cells using the above criteria (28) . If the neuronal marker expression of the trans-new neurons and glial cells to the damaged CNS. Once transplanted into the brain, MSCs can eventually adapt planted hMCSs in our experiments is poor, the expression of human GFAP by immunocytochemical analysis to the region of engraftment by differentiating into the appropriate neuronal subpopulations (42, 46, 50) . One of after grafting of hMSCs represents unequivocal data that further complement previous observations in a large se-the most important questions is whether transdifferentiated neuronal cells from bone marrow become func-ries of cultured hMSCs, demonstrating limited expression of the astroglial marker GFAP after systematic tional neurons. The neuronal cells are defined not only by polarity in cytology and specific protein expression evaluation of several neuronal induction protocols (6).
In the prospective of a neuroprotection in which degen-in defined locations, but more importantly by their excitability and ability to communicate with other cells by erating neurons may be saved, increasing the number of normal surrounding astroglial cells (13) , hMSCs acquire possibility of autologous transplantation provide exciting perspectives for the treatment of CNS human dis-further potential as therapeutic agents.
Furthermore, our data demonstrate an undescribed eases such as ALS (48). The described capability to express neurotrophin molecules and receptors give to the neurogenic feature of transplanted hMSCs both in vitro and in vivo, namely the neurotrophin activation. In two hMSCs the potential to positively interact with the recipient without need for integration in the brain circuitry or key studies (8,34), numerous marrow-derived cells were reported to migrate into the brain and to express neu-for replacing lost neurons. Moreover, transplantation of engineered SCs, providing a constant source of neuro-ronal marker genes. The present data further confirm the capability of hMSCs to migrate into the host brain, at trophic factors, may offer several advantages to conventional therapies in neurodegenerative diseases (55). Fur-least in nude mice. The activation of neurotrophins provides a novel marker capable of identifying the grafted ther studies are necessary to investigate whether or not engrafted hMSCs are really neuroprotective and if they cells but, more importantly, may reveal a new neuroprotection mechanism for injured or degenerating neurons.
are able to improve functional outcome in animal models of neurodegenerative diseases. Neurotrophins and their receptors, which are normally involved in neural cell maturation and proliferation dur-
